Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2024
Elizabeth Wasmuth, PhD
Uncovering Therapeutic Vulnerabilities in Oncogenic Hormone Receptor Signaling *The research project that...
Read More
2024
Benjamin Barwick, PhD
Targeting Transcriptional Co-Activators to Overcome Therapeutic Resistance in Multiple Myeloma *One exceptional...
Read More
2024
Anthony Law, MD, PhD
Early detection of Laryngeal Cancer using Machine Learning
Read More
2024
Abhijit Parolia, PhD
Co-targeting NSD1/2 paralogs in AR-driven metastatic castration-resistant prostate cancer
Read More
2024
Andrew Koh, MD
Investigating the mechanisms of immune checkpoint inhibitor therapy resistance in pediatric solid...
Read More
2024
Christina Ferrer, PhD
Investigating Purine Salvage Dependencies in CDKN2A-deleted Pancreatic Metastases
Read More
2024
Nathan Singh, MD
Dynamic regulation of CAR T cell functional states to enhance anti-tumor efficacy
Read More
2024
Ramzi Abboud, MD
Multidimensional – flow cytometry, mass cytometry, single cell RNA sequencing, and serum...
Read More
2023
Kimberly Stegmaier, MD
Therapeutic Targeting of Chromatin Complexes in Neuroblastoma
Read More
2023
Ian Davis, MD, PhD
Novel mechanisms to improve CAR-T cell therapy for pediatric solid tumors
Read More
2023
Shizhen (Jane) Zhu, MD, PhD
Developing Innovative Anti-GD2 CAR-Macrophages for the Treatment of High-Risk Neuroblastoma
Read More
2023
Megan McNerney, MD, PhD
Restoring CUX1 levels in myeloid malignancies of childhood
Read More
2023
Christopher R. Vakoc, MD, PhD
High-resolution functional mapping and in vitro reconstitution of the PAX3-FOXO1 fusion oncoprotein...
Read More
2023
Angelique Whitehurst, PhD
Genetic Dissection of Therapeutic Intervention Targets in Triple Negative Breast Cancer
Read More
2023
Tomi Akinyemiju, PhD
Implementing Evidence-Based Interventions to Enhance Equity in Oncology Genomic Testing
Read More
2023
Daniel Regan, DVM, PhD, DACVP
Combination losartan-toceranib immunotherapy to disrupt the osteosarcoma tumor microenvironment and improve fibroblast...
Read More